Skip to main content
Log in

Evaluation of ciprofloxacin and doxycycline in the treatment of mediterranean spotted fever

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

A comparison was made of the results obtained with ciprofloxacin (750 mg/12 h) and doxycycline (100 mg/12 h), both administered p.o. for one week, in 34 and 36 patients respectively with Mediterranean spotted fever. Apyrexia was achieved after 50.1 ± 34.2 h (mean ± SD) of antibiotic therapy in the group of patients treated with ciprofloxacin and in 55.2 ± 23.3 h in the group treated with doxycycline (no significant statistical differences). Resolution of the remaining signs and symptoms of the disease was achieved faster with ciprofloxacin. Both therapeutic regimens were effective and safe. Although more expensive than doxycycline, ciprofloxacin is a bactericidal compound which is better tolerated and has a lower risk of toxicity and of development of resistance. It can be considered, together with doxycycline, as an antibiotic of first choice in the treatment of Mediterranean spotted fever.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bernard JG, Bereni J, Hainaut J: Aspect actuel des rickettsioses en Algérie. Bulletin de la Societé de Pathologie Exotique 1963, 56: 620–628.

    Google Scholar 

  2. Gear JHS, Miller GB, Martin H, Swanpoel R, Wolstenholme B, Coppin A: Tickbite fever in South Africa. The occurrence of severe cases on the Witwatersrand. South African Journal of Medical Sciences 1983, 63: 307–310.

    Google Scholar 

  3. Gutman A, Schreiber H, Toragan R: An outbreak of tick typhus in the coastal plains of Israel. Transactions of the Royal Society of Tropical Medicine and Hygiene 1973, 67: 112–121.

    Article  PubMed  Google Scholar 

  4. Raoult D, Nicolas N, De Micco P, Gallais H, Casanova P: Aspects épidémiologiques de la fièvre boutonneuse méditerraneéne en Corse du Sud. Bulletin de la Societé de Pathologie Exotique 1985, 78: 446–451.

    Google Scholar 

  5. Weyer F: Progress in ecology and epidemiology of rickettsioses. Acta Tropica 1978, 35: 5–21.

    PubMed  Google Scholar 

  6. Stille W: Tick-borne spotted fever (“fièvre boutonneuse”) as an imported infection. Deutsche Medizinische Wochenschrift 1971, 96: 116–118.

    Google Scholar 

  7. Anderson JF, Magnarelli LA, Burgdorfer W, Casper EA, Philip RM: Importation into the United States from Africa ofRhipicephalus simus on a boutonneuse fever patient. American Journal of Tropical Medicine and Hygiene 1981, 30: 897–899.

    PubMed  Google Scholar 

  8. Barret-Connor E, Ginsberg MM: Imported South African tick typus. Western Journal of Medicine 1983, 138: 264–266.

    PubMed  Google Scholar 

  9. Schaeffer F, Lederer K, Mates SM: Mediterranean spotted fever in an American woman. Archives of Internal Medicine 1985, 145: 1753–1754.

    Google Scholar 

  10. Harris RL, Kaplan SL, Bradshaw MW, William TW: Boutonneuse fever in American travellers. Journal of Infectious Diseases 1986, 153: 126–128.

    PubMed  Google Scholar 

  11. Raoult D: Antibiotic susceptibility ofRickettsia and treatment of rickettsioses. European Journal of Epidemiology 1989, 5: 432–435.

    Article  PubMed  Google Scholar 

  12. Muñoz-Espín T, López-Pares P, Espejo-Arenas E, Font Creus B, Martínez-Vila I, Travesía-Casanova J, Segura-Porta F, Bella-Cueto F: Erythromycin versus tetracycline for treatment of Mediterranean spotted fever. Archives of Diseases of Childhood 1986, 61: 1027–1029.

    Google Scholar 

  13. Raoult D, Gallais H, de Micco P, Casanova P: Ciprofloxacin therapy for Mediterranean spotted fever. Antimicrobial Agents and Chemotherapy 1988, 3: 606–607.

    Google Scholar 

  14. Petrosillo M, Anzalone E, Casinelli K, Campoli A, Corbo A, Gallo A, Tersigni I, Maddaluno R: Pefloxacin in the treatment of Boutonneuse fever. In: Kazar J, Raoult D (ed): Rickettsiae and rickettsial diseases. Publishing House of the Slovak Academy of Sciencies, Bratislava, 1991, p. 718–721.

    Google Scholar 

  15. Gudiol F, Pallares R, Carratalá J, Bolao F, Ariza J, Rufi G, Viladrich PF: Randomized double-blind evaluation of ciprofloxacin and doxycycline for Mediterranean spotted fever. Antimicrobial Agents and Chemotherapy 1989, 33: 987–988.

    PubMed  Google Scholar 

  16. Ruiz Beltrán R, Herrero Herrero JI, Martín Sánchez AM, Vicente García V, Sanz Ortega F, Mateos Sánchez A, Querol Prieto R, Portugal Alvarez J: Formas graves de fiebre exantemática mediterránea. Análisis prospectivo de 71 enfermos. Anales de Medicina Interna 1985, 2: 365–368.

    Google Scholar 

  17. Dermatino G, Narciso P, Struglia C, Zechini F, Visco G: Esperience terapeutiche nella rickettsiosi conorii con monodose di doxiciclina. Clinique Terapeutiche 1981, 97: 59–62.

    Google Scholar 

  18. Bella-Cueto F, Font-Creus B, Segura-Porta F, Espejo-Arenas E, López-Pares P, Muñoz-Espín T: Comparative randomized trial of one-day doxycycline versus 10-day tetracycline therapy for Mediterranean spotted fever. Journal of Infectious Diseases 1987, 155: 1056–1058.

    PubMed  Google Scholar 

  19. Yagupski P, Gross EM, Alkan M, Bearman JE: Comparison of two dosage schedules of doxycycline in children with rickettsial spotted fever. Journal of Infectious Diseases 1987, 155: 1215–1219.

    PubMed  Google Scholar 

  20. Huys J, Kayihigi J, Freyeiss P, Berghe GJ: Single-dose treatment of epidemic typhus with doxycycline. Chemotherapy 1973, 18: 314–317.

    PubMed  Google Scholar 

  21. Krause DW, Perine PL, McDade JE, Awoke S: Treatment of louse-borne typhus with chloramphenicol, tetracycline or doxycycline. East African Medical Journal 1975, 52: 421–427.

    PubMed  Google Scholar 

  22. Brown GW, Saunders JP, Sadhu S, Huxsoll DL, Shirai A: Single dose doxycycline therapy for scrub thyphus. Transactions of the Royal Society of Tropical Medicine and Hygiene 1987, 72: 412–416.

    Article  Google Scholar 

  23. Hooper DC, Wolfson JS: The fluoroquinolones: pharmacology, clinical uses and toxicities in humans. Antimicrobial Agents and Chemotherapy 1985, 28: 716–721.

    PubMed  Google Scholar 

  24. Raoult D, Roussellier P, Galicher V, Pérez R, Tamalet J: In vitro susceptibility ofRickettsia conorii to ciprofloxacin as determined by suppressing lethality in chicken and by plaque assay. Antimicrobial Agents and Chemotherapy 1985, 29: 424–425.

    Google Scholar 

  25. McClain JB, Joshi B, Rice R: Chloramphenicol, gentamicin, and ciprofloxacin against murine scrub typhus. Antimicrobial Agents and Chemotherapy 1988, 32: 285–286.

    PubMed  Google Scholar 

  26. Ruiz Beltrán R, Herrero Herrero JI, Walker DH, Cuñado Rodríguez A: Mechanism of upper gastro-intestinal hemorrhage in Mediterranean spotted fever. Tropical and Geographical Medicine 1990, 42: 78–82.

    PubMed  Google Scholar 

  27. Smith JT: The mode of action of 4-quinolones and possible mechanisms of resistance. Journal of Antimicrobial Chemotherapy 1985, 18, Supplement D: 21–29.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruiz Beltrán, R., Herrero Herrero, J.I. Evaluation of ciprofloxacin and doxycycline in the treatment of mediterranean spotted fever. Eur. J. Clin. Microbiol. Infect. Dis. 11, 427–431 (1992). https://doi.org/10.1007/BF01961857

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01961857

Keywords

Navigation